Monday, October 17, 2022 7:12:19 PM
So, here’s my take in today’s trading.
For context, this stock trades at very low volume. It’s not the kind of stock that market makers are all that focused, other than letting the trading algorithms do their thing - that’s what HFT is all about. The total value of all trades today was less than $1.4 million and that’s all trades from the universe of retail investors. If today’s action was designed to make it easy for short sellers to cover, there must not be much in the way of shorts.
What I believe happened is a single investor, perhaps a warrant holder taking profits, pulled the trigger to sell in the morning once it became obvious that volume remained low and there wasn’t much movement to the upside on the price.
When it became clear the selling had abated late in the day, the price began to stabilize and move up a bit. I actually bought shares figuring the share price had bottomed and was in an oversold position. I also believe that news of the news may be real this time — just my intuition.
For context, this stock trades at very low volume. It’s not the kind of stock that market makers are all that focused, other than letting the trading algorithms do their thing - that’s what HFT is all about. The total value of all trades today was less than $1.4 million and that’s all trades from the universe of retail investors. If today’s action was designed to make it easy for short sellers to cover, there must not be much in the way of shorts.
What I believe happened is a single investor, perhaps a warrant holder taking profits, pulled the trigger to sell in the morning once it became obvious that volume remained low and there wasn’t much movement to the upside on the price.
When it became clear the selling had abated late in the day, the price began to stabilize and move up a bit. I actually bought shares figuring the share price had bottomed and was in an oversold position. I also believe that news of the news may be real this time — just my intuition.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
